Medical device company Masimo Corp. said it has received clearance from the Federal Drug Administration to sell its patient monitoring system, Rad-97 Pulse CO-Oximeter.
Irvine, California-based Masimo(Nasdaq: MASI), said its Rad-97, which provides noninvasive and continuous monitoring of patients in healthcare settings, is a compact, standalone monitor that incorporates advanced customizability, connectivity and device integration capabilities.
“We’re excited to bring the easy-to-use, compact…
Medical device company Masimo Corp. said it has received clearance from the Federal Drug Administration to sell its patient monitoring system, Rad-97 Pulse CO-Oximeter.
Irvine, California-based Masimo(Nasdaq: MASI), said its Rad-97, which provides noninvasive and continuous monitoring of patients in healthcare settings, is a compact, standalone monitor that incorporates advanced customizability, connectivity and device integration capabilities.
“We’re excited to bring the easy-to-use, compact…